These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35659662)

  • 1. Multiple Plasmodium falciparum drug resistance polymorphisms identified in a pregnant woman with severe malaria and a concomitant spontaneous abortion in Cross River, Nigeria, West Africa.
    Oboh MA; Faal F; Adeniji OE; Correa S; Amawu AU; Ogban E; Heinz E; Hughes G; Meremikwu MM; Amambua-Ngwa A
    Malar J; 2022 Jun; 21(1):160. PubMed ID: 35659662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UK malaria treatment guidelines 2016.
    Lalloo DG; Shingadia D; Bell DJ; Beeching NJ; Whitty CJM; Chiodini PL;
    J Infect; 2016 Jun; 72(6):635-649. PubMed ID: 26880088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artesunate-amodiaquine and artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in Liberia: in vivo efficacy and frequency of molecular markers.
    Koko VS; Warsame M; Vonhm B; Jeuronlon MK; Menard D; Ma L; Taweh F; Tehmeh L; Nyansaiye P; Pratt OJ; Parwon S; Kamara P; Asinya M; Kollie A; Ringwald P
    Malar J; 2022 Apr; 21(1):134. PubMed ID: 35477399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of artemether-lumefantrine for treating uncomplicated Plasmodium falciparum cases and molecular surveillance of drug resistance genes in Western Myanmar.
    Wu Y; Soe MT; Aung PL; Zhao L; Zeng W; Menezes L; Yang Z; Kyaw MP; Cui L
    Malar J; 2020 Aug; 19(1):304. PubMed ID: 32854686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UK malaria treatment guidelines.
    Lalloo DG; Shingadia D; Pasvol G; Chiodini PL; Whitty CJ; Beeching NJ; Hill DR; Warrell DA; Bannister BA;
    J Infect; 2007 Feb; 54(2):111-21. PubMed ID: 17215045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A barcode of multilocus nuclear DNA identifies genetic relatedness in pre- and post-Artemether/Lumefantrine treated Plasmodium falciparum in Nigeria.
    Oyebola KM; Aina OO; Idowu ET; Olukosi YA; Ajibaye OS; Otubanjo OA; Awolola TS; Awandare GA; Amambua-Ngwa A
    BMC Infect Dis; 2018 Aug; 18(1):392. PubMed ID: 30103683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and factors associated with carriage of Pfmdr1 polymorphisms among pregnant women receiving intermittent preventive treatment with sulfadoxine-pyrimethamine (IPTp-SP) and artemether-lumefantrine for malaria treatment in Burkina Faso.
    Natama HM; Toussaint R; Bazié DLC; Samadoulougou S; Coulibaly-Traoré M; Tinto H; Kirakoya-Samadoulougou F
    Malar J; 2020 Nov; 19(1):399. PubMed ID: 33172485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the therapeutic efficacy of artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in northern KwaZulu-Natal: an observational cohort study.
    Vaughan-Williams CH; Raman J; Raswiswi E; Immelman E; Reichel H; Gate K; Knight S
    Malar J; 2012 Dec; 11():434. PubMed ID: 23272998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parasite clearance, cure rate, post-treatment prophylaxis and safety of standard 3-day versus an extended 6-day treatment of artemether-lumefantrine and a single low-dose primaquine for uncomplicated Plasmodium falciparum malaria in Bagamoyo district, Tanzania: a randomized controlled trial.
    Mhamilawa LE; Ngasala B; Morris U; Kitabi EN; Barnes R; Soe AP; Mmbando BP; Björkman A; Mårtensson A
    Malar J; 2020 Jun; 19(1):216. PubMed ID: 32576258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmodium falciparum multidrug resistance gene-1 polymorphisms in Northern Nigeria: implications for the continued use of artemether-lumefantrine in the region.
    Adamu A; Jada MS; Haruna HMS; Yakubu BO; Ibrahim MA; Balogun EO; Sakura T; Inaoka DK; Kita K; Hirayama K; Culleton R; Shuaibu MN
    Malar J; 2020 Nov; 19(1):439. PubMed ID: 33256739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of 3-day low dose quinine plus clindamycin versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children (CLINDAQUINE): an open-label randomized trial.
    Obonyo CO; Juma EA; Were VO; Ogutu BR
    Malar J; 2022 Feb; 21(1):30. PubMed ID: 35109841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermittent screening and treatment with artemether-lumefantrine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in pregnancy: a facility-based, open-label, non-inferiority trial in Nigeria.
    Esu E; Berens-Riha N; Pritsch M; Nwachuku N; Loescher T; Meremikwu M
    Malar J; 2018 Jul; 17(1):251. PubMed ID: 29976228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence to antimalarial drug policy among doctors in Delta State, Nigeria: implications for malaria control.
    Obiebi IP
    Ghana Med J; 2019 Jun; 53(2):109-116. PubMed ID: 31481806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Randomized Controlled Trial of Three- versus Five-Day Artemether-Lumefantrine Regimens for Treatment of Uncomplicated Plasmodium falciparum Malaria in Pregnancy in Africa.
    Onyamboko MA; Hoglund RM; Lee SJ; Kabedi C; Kayembe D; Badjanga BB; Turner GDH; Jackson NV; Tarning J; McGready R; Nosten F; White NJ; Day NPJ; Fanello C
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31818818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ex vivo anti-malarial drug susceptibility of Plasmodium falciparum isolates from pregnant women in an area of highly seasonal transmission in Burkina Faso.
    Tahita MC; Tinto H; Yarga S; Kazienga A; Traore Coulibaly M; Valea I; Van Overmeir C; Rosanas-Urgell A; Ouedraogo JB; Guiguemde RT; van Geertruyden JP; Erhart A; D'Alessandro U
    Malar J; 2015 Jun; 14():251. PubMed ID: 26088768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Where have all the parasites gone? Unusual
    Nakakana UN; Onankpa BO; Mohammed IA; Jega RM; Jiya NM
    F1000Res; 2020; 9():301. PubMed ID: 33214872
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug treatment and prevention of malaria in pregnancy: a critical review of the guidelines.
    Al Khaja KAJ; Sequeira RP
    Malar J; 2021 Jan; 20(1):62. PubMed ID: 33485330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial.
    van der Pluijm RW; Tripura R; Hoglund RM; Pyae Phyo A; Lek D; Ul Islam A; Anvikar AR; Satpathi P; Satpathi S; Behera PK; Tripura A; Baidya S; Onyamboko M; Chau NH; Sovann Y; Suon S; Sreng S; Mao S; Oun S; Yen S; Amaratunga C; Chutasmit K; Saelow C; Runcharern R; Kaewmok W; Hoa NT; Thanh NV; Hanboonkunupakarn B; Callery JJ; Mohanty AK; Heaton J; Thant M; Gantait K; Ghosh T; Amato R; Pearson RD; Jacob CG; Gonçalves S; Mukaka M; Waithira N; Woodrow CJ; Grobusch MP; van Vugt M; Fairhurst RM; Cheah PY; Peto TJ; von Seidlein L; Dhorda M; Maude RJ; Winterberg M; Thuy-Nhien NT; Kwiatkowski DP; Imwong M; Jittamala P; Lin K; Hlaing TM; Chotivanich K; Huy R; Fanello C; Ashley E; Mayxay M; Newton PN; Hien TT; Valecha N; Smithuis F; Pukrittayakamee S; Faiz A; Miotto O; Tarning J; Day NPJ; White NJ; Dondorp AM;
    Lancet; 2020 Apr; 395(10233):1345-1360. PubMed ID: 32171078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro susceptibility of P. falciparum isolates from Abidjan (Côte d'Ivoire) to quinine, artesunate and chloroquine].
    Touré AO; Koné LP; Jambou R; Konan TD; Demba S; Beugre GE; Koné M
    Sante; 2008; 18(1):43-7. PubMed ID: 18684691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triple therapy with artemether-lumefantrine plus amodiaquine versus artemether-lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial.
    Peto TJ; Tripura R; Callery JJ; Lek D; Nghia HDT; Nguon C; Thuong NTH; van der Pluijm RW; Dung NTP; Sokha M; Van Luong V; Long LT; Sovann Y; Duanguppama J; Waithira N; Hoglund RM; Chotsiri P; Chau NH; Ruecker A; Amaratunga C; Dhorda M; Miotto O; Maude RJ; Rekol H; Chotivanich K; Tarning J; von Seidlein L; Imwong M; Mukaka M; Day NPJ; Hien TT; White NJ; Dondorp AM
    Lancet Infect Dis; 2022 Jun; 22(6):867-878. PubMed ID: 35276064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.